Urea

Urea

SCHEMBL697365

Clc1nc(Cl)nc(Cl)n1.NC(N)=O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
TSHR P16473 2/20 0.57
ALOX15 P16050 1/20 0.57
LMNA P02545 4/20 0.55
TDP1 Q9NUW8 3/20 0.43
OR51E2 Q9H255 1/20 0.43
POLB P06746 2/20 0.34
SIRT6 Q8N6T7 1/20 0.33
KDM4E B2RXH2 3/20 0.32
GLA P06280 3/20 0.32
HPGD P15428 3/20 0.32
HSD17B10 Q99714 3/20 0.32
SLC9A1 P19634 3/20 0.32
GAA P10253 2/20 0.32
PLAU P00749 2/20 0.32
CYP1A2 P05177 2/20 0.32
SLC22A1 O15245 1/20 0.32
HTR1A P08908 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAOA P21397 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28396458 0.82 LMNA (0.52) ALDH1A1TSHRALOX15LMNAPOLB
Acetone SCHEMBL10636901 0.79 ALDH1A1 (0.57) ALDH1A1TSHRALOX15LMNATDP1
Urea SCHEMBL28952838 0.76
Bicarbonate SCHEMBL15346242 0.76 ALDH1A1 (0.53) ALDH1A1TSHRALOX15LMNABLM
SCHEMBL7611193 0.76 LMNA (0.41) ALDH1A1TSHRALOX15LMNATDP1
SCHEMBL20781 0.76
SCHEMBL1332087 0.76
Ammonia Solution, Strong SCHEMBL10340047 0.76 ALDH1A1 (1.00) ALDH1A1TSHRALOX15LMNATDP1
SCHEMBL9137101 0.74 POLB (0.52) ALDH1A1TSHRALOX15LMNATDP1
Phosphonic Acid SCHEMBL7528825 0.71 ALDH1A1 (0.57) ALDH1A1TSHRALOX15LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423223-B1 NOVEL EXENDIN VARIANT AND CONJUGATE THEREOF PEGBIO CO LTD (CN) 2015-04-15 EP disclosed
US-8575097-B2 Exendin variant and conjugate thereof PEGBIO CO., LTD. (CN) 2013-11-05 US disclosed
US-20120196795-A1 NOVEL EXENDIN VARIANT AND CONJUGATE THEREOF PEGBIO CO., LTD. (CN) 2012-08-02 US disclosed
EP-2423223-A1 NOVEL EXENDIN VARIANT AND CONJUGATE THEREOF Pegbio Co., Ltd. (CN) 2012-02-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196795-A1 NOVEL EXENDIN VARIANT AND CONJUGATE THEREOF GLP1R, IAPP, GIPR ALDH1A1 4434/4885TSHR 1596/4885ALOX15 1333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.